311 related articles for article (PubMed ID: 28332571)
1. Profiling protein expression in circulating tumour cells using microfluidic western blotting.
Sinkala E; Sollier-Christen E; Renier C; Rosàs-Canyelles E; Che J; Heirich K; Duncombe TA; Vlassakis J; Yamauchi KA; Huang H; Jeffrey SS; Herr AE
Nat Commun; 2017 Mar; 8():14622. PubMed ID: 28332571
[TBL] [Abstract][Full Text] [Related]
2. An integrated microfluidic chip system for single-cell secretion profiling of rare circulating tumor cells.
Deng Y; Zhang Y; Sun S; Wang Z; Wang M; Yu B; Czajkowsky DM; Liu B; Li Y; Wei W; Shi Q
Sci Rep; 2014 Dec; 4():7499. PubMed ID: 25511131
[TBL] [Abstract][Full Text] [Related]
3. Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines.
Powell AA; Talasaz AH; Zhang H; Coram MA; Reddy A; Deng G; Telli ML; Advani RH; Carlson RW; Mollick JA; Sheth S; Kurian AW; Ford JM; Stockdale FE; Quake SR; Pease RF; Mindrinos MN; Bhanot G; Dairkee SH; Davis RW; Jeffrey SS
PLoS One; 2012; 7(5):e33788. PubMed ID: 22586443
[TBL] [Abstract][Full Text] [Related]
4. Correlation of hormone receptor status between circulating tumor cells, primary tumor, and metastasis in breast cancer patients.
Kalinsky K; Mayer JA; Xu X; Pham T; Wong KL; Villarin E; Pircher TJ; Brown M; Maurer MA; Bischoff FZ
Clin Transl Oncol; 2015 Jul; 17(7):539-46. PubMed ID: 25613123
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients.
Aktas B; Kasimir-Bauer S; Müller V; Janni W; Fehm T; Wallwiener D; Pantel K; Tewes M;
BMC Cancer; 2016 Jul; 16():522. PubMed ID: 27456970
[TBL] [Abstract][Full Text] [Related]
6. Genetic Heterogeneity of Single Circulating Tumour Cells in Colorectal Carcinoma.
Hamid FB; Gopalan V; Matos M; Lu CT; Lam AK
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092235
[TBL] [Abstract][Full Text] [Related]
7. High-Throughput Microfluidic Labyrinth for the Label-free Isolation of Circulating Tumor Cells.
Lin E; Rivera-Báez L; Fouladdel S; Yoon HJ; Guthrie S; Wieger J; Deol Y; Keller E; Sahai V; Simeone DM; Burness ML; Azizi E; Wicha MS; Nagrath S
Cell Syst; 2017 Sep; 5(3):295-304.e4. PubMed ID: 28941584
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Impact of HER2 and ER Status of Circulating Tumor Cells in Metastatic Breast Cancer Patients with a HER2-Negative Primary Tumor.
Beije N; Onstenk W; Kraan J; Sieuwerts AM; Hamberg P; Dirix LY; Brouwer A; de Jongh FE; Jager A; Seynaeve CM; Van NM; Foekens JA; Martens JW; Sleijfer S
Neoplasia; 2016 Nov; 18(11):647-653. PubMed ID: 27764697
[TBL] [Abstract][Full Text] [Related]
9. Optofluidic real-time cell sorter for longitudinal CTC studies in mouse models of cancer.
Hamza B; Ng SR; Prakadan SM; Delgado FF; Chin CR; King EM; Yang LF; Davidson SM; DeGouveia KL; Cermak N; Navia AW; Winter PS; Drake RS; Tammela T; Li CM; Papagiannakopoulos T; Gupta AJ; Shaw Bagnall J; Knudsen SM; Vander Heiden MG; Wasserman SC; Jacks T; Shalek AK; Manalis SR
Proc Natl Acad Sci U S A; 2019 Feb; 116(6):2232-2236. PubMed ID: 30674677
[TBL] [Abstract][Full Text] [Related]
10. Identification of genomic signatures in circulating tumor cells from breast cancer.
Kanwar N; Hu P; Bedard P; Clemons M; McCready D; Done SJ
Int J Cancer; 2015 Jul; 137(2):332-44. PubMed ID: 25529931
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic characterization of circulating tumor cells in triple negative breast cancer patients.
Agelaki S; Dragolia M; Markonanolaki H; Alkahtani S; Stournaras C; Georgoulias V; Kallergi G
Oncotarget; 2017 Jan; 8(3):5309-5322. PubMed ID: 28029660
[TBL] [Abstract][Full Text] [Related]
12. Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis.
Giuliano M; Herrera S; Christiny P; Shaw C; Creighton CJ; Mitchell T; Bhat R; Zhang X; Mao S; Dobrolecki LE; Al-rawi A; Chen F; Veneziani BM; Zhang XH; Hilsenbeck SG; Contreras A; Gutierrez C; Jeselsohn RM; Rimawi MF; Osborne CK; Lewis MT; Schiff R; Trivedi MV
Breast Cancer Res; 2015 Jan; 17(1):3. PubMed ID: 25572662
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of circulating tumor cells from patients with metastatic breast cancer reflects evolutionary changes in gene expression under the pressure of systemic therapy.
Aaltonen KE; Novosadová V; Bendahl PO; Graffman C; Larsson AM; Rydén L
Oncotarget; 2017 Jul; 8(28):45544-45565. PubMed ID: 28489591
[TBL] [Abstract][Full Text] [Related]
14. Microfluidics and circulating tumor cells.
Dong Y; Skelley AM; Merdek KD; Sprott KM; Jiang C; Pierceall WE; Lin J; Stocum M; Carney WP; Smirnov DA
J Mol Diagn; 2013 Mar; 15(2):149-57. PubMed ID: 23266318
[TBL] [Abstract][Full Text] [Related]
15. Single nucleotide variant profiles of viable single circulating tumour cells reveal CTC behaviours in breast cancer.
Wang Y; Guo L; Feng L; Zhang W; Xiao T; Di X; Chen G; Zhang K
Oncol Rep; 2018 May; 39(5):2147-2159. PubMed ID: 29565466
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort.
Jansson S; Bendahl PO; Larsson AM; Aaltonen KE; Rydén L
BMC Cancer; 2016 Jul; 16():433. PubMed ID: 27390845
[TBL] [Abstract][Full Text] [Related]
17. A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation.
Frithiof H; Welinder C; Larsson AM; Rydén L; Aaltonen K
J Transl Med; 2015 Apr; 13():126. PubMed ID: 25896421
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiles of circulating tumor cells versus primary tumors in metastatic breast cancer.
Onstenk W; Sieuwerts AM; Weekhout M; Mostert B; Reijm EA; van Deurzen CH; Bolt-de Vries JB; Peeters DJ; Hamberg P; Seynaeve C; Jager A; de Jongh FE; Smid M; Dirix LY; Kehrer DF; van Galen A; Ramirez-Moreno R; Kraan J; Van M; Gratama JW; Martens JW; Foekens JA; Sleijfer S
Cancer Lett; 2015 Jun; 362(1):36-44. PubMed ID: 25797316
[TBL] [Abstract][Full Text] [Related]
19. Highly multiplexed profiling of cell surface proteins on single circulating tumor cells based on antibody and cellular barcoding.
Wang C; Yang L; Wang Z; He J; Shi Q
Anal Bioanal Chem; 2019 Aug; 411(21):5373-5382. PubMed ID: 30820628
[TBL] [Abstract][Full Text] [Related]
20. Variable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of patients with metastatic breast cancer.
Polioudaki H; Agelaki S; Chiotaki R; Politaki E; Mavroudis D; Matikas A; Georgoulias V; Theodoropoulos PA
BMC Cancer; 2015 May; 15():399. PubMed ID: 25962645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
